| Oct 29 |
Novartis Stock Dives on $800 Million Write-Down
|
| Oct 29 |
Novartis Ag (NVS) Q3 2024 Earnings Call Transcript
|
| Oct 29 |
Top Midday Stories: McDonald's Beats Estimates on Q3 EPS, Revenue, Misses on Same-Store Sales; Ford Lowers EBIT Guidance
|
| Oct 29 |
Novartis AG (NVS) Q3 2024 Earnings Call Transcript
|
| Oct 29 |
Monte Rosa Therapeutics price target raised to $20 from $16 at Piper Sandler
|
| Oct 29 |
Novartis Sacrifices A Flat Base On Lagging Sales Of Its Biggest Moneymaker
|
| Oct 29 |
Monte Rosa Therapeutics Shares Skyrocket After $2.1 Billion Deal with Novartis
|
| Oct 29 |
Novartis Beats on Q3 Earnings and Sales, Raises 2024 Outlook
|
| Oct 29 |
Novartis (NVS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
|
| Oct 29 |
Novartis AG 2024 Q3 - Results - Earnings Call Presentation
|
